60 Degrees Pharmaceuticals, Inc. Common StockSXTP

60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and commercializing new medicines for the treatment and prevention of vector-borne disease. The Company achieved U.S. Food and Drug Administration approval of its lead product, ARAKODA® ( tafenoquine ), for malaria prevention in.

60degreespharma.com